Tomi P

Executive Officer

   Professor Tomi P. Mäkelä is Executive Officer of the iCAN Digital Precision Cancer Medicine Flagship project - a public-private partnership aiming for discoveries and improved treatments at the intersection of molecular and digital health.  Mäkelä is recognized for his work on signaling and its deregulation in cancer focusing recently on tumor suppressor kinase LKB1. He is an EMBO Member, and member of the Finnish Academy of Science and Letters and acts on the Board of EU Mission Cancer.